Investigating the Relationship Between the Expression Level of Mucin Gene Cluster (MUC2, MUC5A, and MUC5B) and Clinicopathological Characterization of Colorectal Cancer

Overview

Journal Galen Med J

Specialty General Medicine

Date 2022 May 16

PMID 35572847

Authors

Hossein Iranmanesh

Ahmad Majd

Ehsan Nazemalhosseini Mojarad

Mohammad Reza Zali

Mehrdad Hashemi

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer (CRC) is one of the most common cancers in the world and has a high mortality rate. It is accepted that dysfunction in the expression of mucins are associated with the occurrence and development of CRC. Therefore, the present study aimed to investigate the expression of MUC2, MUC5A, and MUC5B genes in CRC and their relationship with clinicopathological variables.

Materials And Methods: The population included 28 patients after a colonoscopy and confirmation of the results. Tumors and parallel adjacent normal tissues from CRC patients were collected. RNA extraction and cDNA synthesis were performed using the corresponding kits. The gene primer was designed and RT-PCR was used to evaluate gene expression. The t-test and ANOVA were used to examine the differences between the different groups. Data analysis was performed using Prism8 software. Tumors from CRC patients were retrospectively collected from Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Results: The results showed that the expression of MUC2, MUC5A, and MUC5B genes was lower in patients with CRC aged 50 years or younger than was in older patients (P<0.05). Only the MUC5B gene expression was associated with tumor grades, which was higher in poorly differentiated tumors. The expression of MUC5A and MUC2 genes was higher in stage IV of the tumor than in other stages (P<0.05). Conclusion: Among the changes in the expression of MUC secretory genes, including MUC2, MUC5A, and MUC5B and clinicopathological variables, there was a relationship that could have prognostic and diagnostic value in CRC.

Conclusion: None.

Citing Articles

Impact of mini-driver genes in the prognosis and tumor features of colorectal cancer samples: a novel perspective to support current biomarkers.

Campos Segura A, Velasquez Sotomayor M, Gutierrez Roman A, Rojas C, Murillo Carrasco A PeerJ. 2023; 11:e15410.

PMID: 37214090 PMC: 10198153. DOI: 10.7717/peerj.15410.

The Mucin Family of Proteins: Candidates as Potential Biomarkers for Colon Cancer.

Cox K, Liu S, Lwin T, Hoffman R, Batra S, Bouvet M Cancers (Basel). 2023; 15(5).

PMID: 36900282 PMC: 10000725. DOI: 10.3390/cancers15051491.

Mutational Impacts on the N and C Terminal Domains of the MUC5B Protein: A Transcriptomics and Structural Biology Study.

Mehmood A, Nawab S, Jin Y, Kaushik A, Wei D ACS Omega. 2023; 8(4):3726-3735.

PMID: 36743039 PMC: 9893249. DOI: 10.1021/acsomega.2c04871.

References

Buisine M, Janin A, Maunoury V, Audie J, Delescaut M, Copin M . Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology. 1996; 110(1):84-91. DOI: 10.1053/gast.1996.v110.pm8536891. View

Rakha E, Boyce R, Abd El-Rehim D, Kurien T, Green A, Paish E . Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol. 2005; 18(10):1295-304. DOI: 10.1038/modpathol.3800445. View

Bartman A, Sanderson S, Ewing S, Niehans G, Wiehr C, Evans M . Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer. 1999; 80(2):210-8. DOI: 10.1002/(sici)1097-0215(19990118)80:2<210::aid-ijc9>3.0.co;2-u. View

Lech G, Slotwinski R, Slodkowski M, Krasnodebski I . Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances. World J Gastroenterol. 2016; 22(5):1745-55. PMC: 4724606. DOI: 10.3748/wjg.v22.i5.1745. View

Pigny P, Guyonnet-Duperat V, HILL A, Pratt W, dHooge M, Laine A . Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics. 1996; 38(3):340-52. DOI: 10.1006/geno.1996.0637. View

McCool D, Forstner J, FORSTNER G . Regulated and unregulated pathways for MUC2 mucin secretion in human colonic LS180 adenocarcinoma cells are distinct. Biochem J. 1995; 312 ( Pt 1):125-33. PMC: 1136235. DOI: 10.1042/bj3120125. View

Yu C, Yang P, Shun C, Lee Y, Kuo S, Luh K . Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer. Int J Cancer. 1996; 69(6):457-65. DOI: 10.1002/(SICI)1097-0215(19961220)69:6<457::AID-IJC7>3.0.CO;2-3. View

Weiss A, Babyatsky M, Ogata S, Chen A, Itzkowitz S . Expression of MUC2 and MUC3 mRNA in human normal, malignant, and inflammatory intestinal tissues. J Histochem Cytochem. 1996; 44(10):1161-6. DOI: 10.1177/44.10.8813081. View

Imai Y, Yamagishi H, Fukuda K, Ono Y, Inoue T, Ueda Y . Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. World J Gastroenterol. 2013; 19(25):3957-68. PMC: 3703182. DOI: 10.3748/wjg.v19.i25.3957. View

10.

Ajioka Y, Allison L, Jass J . Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol. 1996; 49(7):560-4. PMC: 500570. DOI: 10.1136/jcp.49.7.560. View

11.

Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S . Colorectal cancer in mice genetically deficient in the mucin Muc2. Science. 2002; 295(5560):1726-9. DOI: 10.1126/science.1069094. View

12.

Percinel S, Savas B, Ensari A, Kuzu I, Kuzu M, Bektas M . Mucins in the colorectal neoplastic spectrum with reference to conventional and serrated adenomas. Turk J Gastroenterol. 2007; 18(4):230-8. View

13.

Sonora C, Mazal D, Berois N, Buisine M, Ubillos L, Varangot M . Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues. J Histochem Cytochem. 2005; 54(3):289-99. DOI: 10.1369/jhc.5A6763.2005. View

14.

Hanski C, Hofmeier M, Schmitt-Graff A, Riede E, Hanski M, Borchard F . Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary. J Pathol. 1997; 182(4):385-91. DOI: 10.1002/(SICI)1096-9896(199708)182:4<385::AID-PATH861>3.0.CO;2-Q. View

15.

Sonzogni A, Bianchi F, Fabbri A, Cossa M, Rossi G, Cavazza A . Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma. J Pathol Clin Res. 2017; 3(2):139-152. PMC: 5402180. DOI: 10.1002/cjp2.67. View

16.

Perrais M, Pigny P, Buisine M, Porchet N, Aubert J . Aberrant expression of human mucin gene MUC5B in gastric carcinoma and cancer cells. Identification and regulation of a distal promoter. J Biol Chem. 2001; 276(18):15386-96. DOI: 10.1074/jbc.M010534200. View

17.

Santini D, Baldi A, Vincenzi B, Mellone P, Campioni M, Antinori A . Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma. J Clin Pathol. 2007; 60(9):1069-70. PMC: 1972431. DOI: 10.1136/jcp.2005.035832. View

18.

Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund J . SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol. 2004; 166(1):37-47. PMC: 2172132. DOI: 10.1083/jcb.200311021. View

19.

Ho S, Roberton A, Shekels L, Lyftogt C, Niehans G, Toribara N . Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology. 1995; 109(3):735-47. DOI: 10.1016/0016-5085(95)90380-1. View

20.

Byrd J, Yan P, Sternberg L, Yunker C, Scheiman J, Bresalier R . Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology. 1997; 113(2):455-64. DOI: 10.1053/gast.1997.v113.pm9247464. View